Cargando…

Predictors of seroconversion after coronavirus disease 2019 vaccination

BACKGROUND: Vaccine nonresponse during the coronavirus disease 2019 (COVID-19) pandemic has considerable individual and societal risks. OBJECTIVE: To investigate the clinical characteristics of patients with lack of seroconversion after vaccination against severe acute respiratory syndrome coronavir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiarella, Sergio E., Jenkins, Sarah M., Smith, Carin Y., Prasad, Vikas, Shakuntulla, Fnu, Ahluwalia, Vaibhav, Iyer, Vivek N., Theel, Elitza S., Joshi, Avni Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144839/ https://www.ncbi.nlm.nih.gov/pubmed/35640775 http://dx.doi.org/10.1016/j.anai.2022.05.026

Ejemplares similares

Predictors Of Seroconversion Following COVID-19 Vaccination
por: Chiarella, Sergio, et al.
Publicado: (2022)

Clinical characteristics of subjects with lack of seroconversion following COVID-19 vaccination
por: Ahluwalia, Vaibhav, et al.
Publicado: (2022)

Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency
por: Squire, Jacqueline, et al.
Publicado: (2021)

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021)

Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization: A Review
por: Theel, Elitza S.
Publicado: (2022)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination
por: Dages, Kelley N., et al.
Publicado: (2021)

An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine—a case report
por: Bhan, Chandur, et al.
Publicado: (2021)

COVID-19-Associated Hospitalization and Outcomes in Patients with Asthma: A Systematic Review and Meta-analysis
por: Sitek, Andrea, et al.
Publicado: (2021)

Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017
por: Theel, Elitza S, et al.
Publicado: (2020)

Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report
por: Pitlick, Mitchell M., et al.
Publicado: (2021)

Diagnostic Testing for Zika: Observing Rapid Translation During a Public Health Emergency
por: Kurani, Shaheen, et al.
Publicado: (2017)

Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area
por: Shah, Vishal P., et al.
Publicado: (2020)

Screening for SARS-CoV-2: Health Policy Implications in Low- and Middle-Income Countries
por: Hashmi, Shahrukh K., et al.
Publicado: (2020)

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
por: Theel, Elitza S., et al.
Publicado: (2020)

339. Assessing Utilization of the Venereal Disease Research Laboratory Test in Cerebrospinal Fluid for the Diagnosis of Neurosyphilis: A Cohort Study
por: Sytsma, Terin, et al.
Publicado: (2020)

Coronavirus: Hotspot on coronavirus disease 2019 in India
por: Cheke, Rameshwar S., et al.
Publicado: (2020)

A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study
por: Sendi, Parham, et al.
Publicado: (2021)

Cavitary lung lesions caused by Pneumocystis jirovecii in setting of common variable immune deficiency
por: Zhang, Zhenmei, et al.
Publicado: (2020)

P.062 Human coronavirus NL63 and 229E seroconversion in children
por: van der Hoek, L., et al.
Publicado: (2009)

Negative Troponin I as a Predictor of Survival in Patients With Coronavirus Disease 2019
por: Losiniecki, Fergie J., et al.
Publicado: (2023)

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Staines, Henry M., et al.
Publicado: (2021)

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination
por: Perez, Yalile, et al.
Publicado: (2021)

Factors associated with seroconversion to the major piroplasm surface protein of the bovine haemoparasite Theileria orientalis
por: Jenkins, Cheryl, et al.
Publicado: (2016)

JCV seroconversion rate during the SARS COVID-19 pandemic
por: Vigiser, I., et al.
Publicado: (2022)

753. Performance Characteristics of Diagnostic Assays in Blastomycosis
por: O’Dowd, Timothy, et al.
Publicado: (2020)

Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes
por: Valencia Sanchez, Cristina, et al.
Publicado: (2021)

Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort
por: Cheng, B., et al.
Publicado: (2020)

Hepatobiliary and Pancreatic Manifestations of Coronavirus Disease 2019
por: Singla, Vikas, et al.
Publicado: (2020)

An Unusual Cluster of Neuroinvasive Lyme Disease Cases Presenting With Bannwarth Syndrome in the Midwest United States
por: Shah, Aditya, et al.
Publicado: (2017)

Seroconversion of severe acute respiratory syndrome coronavirus 2–infected patients on immunosuppression: A retrospective analysis
por: Smith, Jeffrey S., et al.
Publicado: (2021)

Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies
por: Wong, Lydia Su Yin, et al.
Publicado: (2023)

Healthcare Worker Seroconversion in SARS Outbreak
por: Chow, Pierce K. H., et al.
Publicado: (2004)

Seroconversion stages COVID19 into distinct pathophysiological states
por: Galbraith, Matthew D., et al.
Publicado: (2020)

Impact of Coronavirus Disease 2019 on the Diagnosis and Therapy for Barrett’s Esophagus and Esophageal Cancer in the United States
por: Trindade, Arvind J., et al.
Publicado: (2022)

Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019
por: Luo, Ying, et al.
Publicado: (2020)

Predictors of in-hospital Outcomes in Patients With Cirrhosis and Coronavirus Disease-2019
por: Elhence, Anshuman, et al.
Publicado: (2022)

Predictors of In-hospital Outcomes in Patients with Cirrhosis and Coronavirus Disease-2019
por: Elhence, Anshuman, et al.
Publicado: (2022)

COVID-19 in patients with B cell immune deficiency
por: Vergidis, Paschalis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dpeem6gecjn4jql6e3rafl332h